In combination with ritonavir, as part of a HIV treatment regimen for
treatment-experienced adult and pediatric patients who have demonstrated failure to at least 2 Protease Inhibitors.
For the treatment of HIV/AIDS. The prescriber must be approved for the Facilitated Access to HIV/AIDS Drug Products mechanism.
